Search - tctmd.com

Displaying 1 - 20 of 40

Sort: Relevancy | Date

Presentation TCT 2016

Case 1: Primary PTCA With High Thrombotic Burden: How Did I Treat it?

Presenter: Ricardo Lluberas, Jeffrey W. Moses, Jamil Abdalla Saad, Gustavo S. Vignolo

October 30, 2016

News Industry News

Spectranetics Receives CE Mark for AngioSculptX™

August 11, 2016

News Industry News

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

July 07, 2016

News Industry News

QT Vascular Receives FDA 510(k) Clearance For Chocolate XD™, A Novel PTCA Balloon

June 28, 2016

News Daily News

比伐卢定标签更新，警告 STEMI 患者 PCI 后的急性支架血栓事件，建议持续输液

Shelley Wood

April 18, 2016

News Daily News

Label Update for Bivalirudin Warns of Acute Stent Thrombosis With PCI for STEMI, Recommends Continued Infusion

Shelley Wood

April 18, 2016

News Daily News

La Actualización del Prospecto de Bivalirudina Advierte del Riesgo de Trombosis Aguda de Stent con PCI para el Manejo de STEMI y Recomienda la Infusión Continuada

Shelley Wood

April 18, 2016

News Industry News

Aralez resubmits to FDA New Drug Application for YOSPRALA

March 15, 2016

Presentation TCT 2015

Early First-in-Human Data of Paclitaxel Drug-Coated Chocolate PTCA Coronary Balloon Catheters in De Novo Coronary Lesions

Presenter: Andrea Abizaid, Daniel Burkhoff, J. A. Mustapha

October 14, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

News Industry News

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

July 23, 2015

News Industry News

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

July 22, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

News Industry News

Cardiovascular Systems Completes Coast Study Enrollment

July 14, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Industry News

China Interventional Cardiovascular Device Industry Report, 2014-2017

May 27, 2015

News Industry News

QT Vascular Announces First Patients Enrolled In Clinical Study Of Chocolate Touch™ PTCA Coronary Drug-Coated Balloon

May 20, 2015

News Industry News

India Coronary Stent Market to be Tripled by 2021

May 05, 2015

News Industry News

Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs

August 19, 2014

News Industry News

Boston Scientific Receives CE Mark For Agent™ Drug-Coated Balloon

July 23, 2014

Advertisement

Case 1: Primary PTCA With High Thrombotic Burden: How Did I Treat it?

Spectranetics Receives CE Mark for AngioSculptX™

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

QT Vascular Receives FDA 510(k) Clearance For Chocolate XD™, A Novel PTCA Balloon

比伐卢定标签更新，警告 STEMI 患者 PCI 后的急性支架血栓事件，建议持续输液

Label Update for Bivalirudin Warns of Acute Stent Thrombosis With PCI for STEMI, Recommends Continued Infusion

La Actualización del Prospecto de Bivalirudina Advierte del Riesgo de Trombosis Aguda de Stent con PCI para el Manejo de STEMI y Recomienda la Infusión Continuada

Aralez resubmits to FDA New Drug Application for YOSPRALA

Early First-in-Human Data of Paclitaxel Drug-Coated Chocolate PTCA Coronary Balloon Catheters in De Novo Coronary Lesions

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

Cardiovascular Systems Completes Coast Study Enrollment

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

China Interventional Cardiovascular Device Industry Report, 2014-2017

QT Vascular Announces First Patients Enrolled In Clinical Study Of Chocolate Touch™ PTCA Coronary Drug-Coated Balloon

India Coronary Stent Market to be Tripled by 2021

Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs

Boston Scientific Receives CE Mark For Agent™ Drug-Coated Balloon

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content